ISMRM Workshop on

Translational Cancer Imaging:

From Acronym to Actuality

calendar_month

12-14 March 2026

location_on

Universidad Autónoma de Madrid (UAM)
Faculty of Medicine
Madrid, Spain

Organizers

Co-Chairs:
Ananth Madhuranthakam, Ph.D.
Pavithra Viswanath, Ph.D.

Local Co-Chair:
Jesus Pacheco-Torres, Ph.D.

Register Now

Early Registration Deadline:

Declarations & Supporters

Faculty declarations will be available approximately two weeks before the workshop begins.

Registration & Travel

Register Now

Early Registration & Cancellation Deadline:
11 February 2026 at 23:59 UTC

Travel & Housing Information

Need a Visa Letter?
Please download & complete this self-fillable PDF letter.

For Presenters & Attendees

Program Options:
Scroll Down | Open Separately

Guidelines for Presenters & Posters

Sustainability

ISMRM Sustainability Initiatives

Overview & Program

Workshop Overview

The ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality is a comprehensive two and a half-day event that aims to bridge the gap between research and clinical practice in cancer imaging. The workshop, set to take place in Madrid, Spain, will cover a wide range of topics related to the use of imaging in cancer diagnosis, treatment planning, and monitoring.

The first session will focus on physicians' perspectives on the use of imaging in patient care for various cancers, including glioblastoma, breast cancer, prostate cancer, and HCC/kidney cancer. The second session will delve into advanced MRI techniques for cancer, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST). The third and fourth sessions will explore the applications of cancer imaging, including genotyping and phenotyping, early detection, stratification, risk characterization, biomarkers for predicting and monitoring therapy response, and image-guided and adaptive therapy. Specific imaging techniques and applications, such as prostate bi-parametric screening, preclinical imaging, PET/MR, radio-genomics, MR-Linac, and intra-operative MRI, will be discussed.

The final session will focus on cancer image analysis, covering topics such as artificial intelligence (AI), machine learning, deep learning, multi-modality imaging, mathematical modeling, and omics. Throughout the workshop, attendees will have the opportunity to participate in oral presentations, poster sessions, and round table discussions, fostering collaboration and knowledge sharing among professionals from various backgrounds.

Overall, the ISMRM Workshop on Translational Cancer Imaging aims to provide a platform for radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers to discuss the latest developments, challenges, and opportunities in translational cancer imaging, ultimately working towards improving patient care and outcomes.

Educational Objectives

Upon completion of this activity, participants should be able to:

Target Audience

The target audience for the ISMRM Workshop on Translational Cancer Imaging will be a multidisciplinary group of professionals involved in cancer imaging research and clinical applications. This likely will include MR physicists, radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers working in the field of cancer imaging.

The workshop covers a wide range of topics, from physicians' perspectives on imaging in patient care to advanced MRI techniques, applications of cancer imaging, and image analysis using AI and machine learning. The diverse content aims to bring together individuals from various backgrounds to discuss and learn about the latest developments, challenges, and opportunities in translational cancer imaging.

The workshop's focus on translating imaging advances into clinical practice further indicates that it is designed for professionals interested in bridging the gap between research and patient care.

Preliminary Program

Day 1 - Thursday, 12 March 2026

07:30

Registration and Speaker Upload Available

08:30

Welcome

Session 1: Physicians’ Perspective on the Use of Imaging in Patient Care

Moderators: T.B.A.

08:40

T.B.A.

09:00

Use of Advanced Imaging in Prostate Cancer Staging, Radiation Treatment Planning and Surveillance

Curtiland Deville Jr., M.D.
Johns Hopkins University
Baltimore, MD, USA

09:20

The Role of MRI in the Diagnosis, Staging and Treatment Selection of Cervical Cancer

T.B.A.

09:40

Breast MRI in Cancer Care: Clinical Utility, Evolving Evidence and Future Directions

T.B.A.

10:00

Round Table Discussion
Questions and Answers

10:30

Break and Speaker Upload Available
Poster Viewing

11:00

Proffered Papers - Oral Session

11:30

Lunch and Speaker Upload Available
Poster Viewing

Session 2: Advanced MRI Techniques for Cancer

Moderators: T.B.A.

13:30

Diffusion MR Microscopy for Cancer Imaging

T.B.A.

13:50

Deuterium Metabolic Imaging for Cancer Research: Principles, Practice, and Potential

Evita C. Wiegers, Ph.D.
University Medical Center Utrecht
Utrecht, The Netherlands

14:10

MR Spectroscopy

T.B.A.

14:30

Amide Proton Transfer weighted CEST MRI in Cancers of the Brain and Beyond

T.B.A.

14:50

Round Table Discussion
Questions and Answers

15:00

Break and Speaker Upload Available
Poster Viewing

15:30

Proffered Papers - Oral Session

16:00

Adjourn

Day 2 - Friday, 13 March 2026

07:30

Registration and Speaker Upload Available

Session 3: Applications of Cancer Imaging: Early Detection, Stratification, Genotyping, and Phenotyping

Moderators: Yan Li, M.B.B.S., Ph.D. and Mahsa Servati, Ph.D.

08:30

From Cells to Systems: Multi-Scale Cancer Imaging for Biomarker Discovery

T.B.A.

08:50

Detecting Oligo-Metastatic Disease in Prostate Cancer

T.B.A.

09:10

PET/MRI in Cancer: Lessons Learned Through Our 10-Year Journey

Tone F. Bathen, Ph.D.
Norwegian University of Science and Technology
Trondheim, Norway

09:30

Radiogenomics for Cancer Characterization: Insights from Kidney and Breast Malignancies

T.B.A.

09:50

Round Table Discussion
Questions and Answers

10:20

Break and Speaker Upload Available
Poster Viewing

11:00

Negendank Lecture: MR Guided Interventions in Cancer

Clare M.C. Tempany-Afdhal, M.D.
Harvard Medical School
Boston, MA, USA

11:45

Questions and Answers

12:00

Lunch and Speaker Upload Available
Poster Viewing

Session 4: Applications of Cancer Imaging: Biomarkers for Prediction and Therapy Response Monitoring and Image-Guided Adaptive Therapy

Moderators: T.B.A.

14:00

Tumour Response to STING Activation Assessed with Multiparametric MRI

Simon P. Robinson, Ph.D.
The Institute of Cancer Research
Sutton, England, UK

14:20

Perfusion Imaging for Monitoring Brain Tumor Therapy

Jan Petr, Ph.D.
Helmholtz-Zentrum Dresden Rossendorf
Dresden, Germany

14:40

Advanced Imaging in the Neurosurgical Treatment of Intra-Axial Brain Tumors

Max Krucoff, M.D.
Medical College of Wisconsin
Milwaukee, WI, USA

15:00

Round Table Discussion
Questions and Answers

15:30

Proffered Papers - Oral Session

16:00

Poster Session

18:00

Adjourn

Day 3 - Saturday, 14 March 2026

08:00

Registration and Speaker Upload Available

Session 5: Cancer Image Analysis: Omics, Mathematical Modeling and Deep-Learning Multimodality Imaging

Moderators: T.B.A.

08:30

Multimodal Learning in Neuro-Oncology: From Imaging Radiomics to Omics Integration

Anahita Kazerooni, Ph.D.
University of Pennsylvania
Philadelphia, PA, USA

08:50

Human Lung Cancer Evaluation with NMR Metabolomics

Leo L. Cheng, Ph.D.
Harvard Medical School
Boston, MA, USA

09:10

Breast MRI With Computational Modeling and Deep Learning

T.B.A.

09:30

Human Brain Tumor Evolution: Seeing Cells, Tracking Mutations and Exploiting Vulnerabilities

T.B.A.

09:50

Round Table Discussion
Questions and Answers

10:30

Adjourn